Syndax Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 46.7 | 66.3 | 1,412.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 223.0 | 107.4 | 204.7 | 223.7 | 213.3 | 100.0 | 159.3 | 76.7 | 88.5 | 79.5 | 94.4 | 193.8 | 156.4 | 183.5 | 248.9 | 396.2 | 430.8 | 674.0 | 760.4 | 585.1 | 73.4 | 8.3 | 7.4 | 8.3 | 11.5 | – | – | – | – | 2,922.5 | 3,783.7 | 433.1 | 99.7 | 47.8 | 24.1 | 10.4 | 12.0 | 10.6 | 9.3 | 7.7 | |
| 2.9 | 1.6 | 3.4 | 2.5 | 2.7 | 2.0 | 4.0 | 2.5 | 3.2 | 2.3 | 2.1 | 5.3 | 5.4 | 8.8 | 7.1 | 4.1 | 5.0 | 4.1 | 5.1 | 4.1 | 5.0 | 2.9 | 2.7 | 3.2 | 4.3 | 3.4 | 3.4 | 3.6 | 2.8 | 2.8 | 4.1 | 4.0 | 4.5 | 3.9 | 4.9 | 5.2 | 11.6 | 28.1 | 48.7 | 129.1 | |
| 217.2 | 93.1 | – | – | 205.0 | 88.9 | 152.3 | 67.8 | 82.2 | 65.8 | 57.0 | 176.5 | 136.5 | 167.6 | 232.9 | 374.2 | 407.1 | 611.5 | 731.7 | 553.9 | 69.7 | 6.9 | 6.2 | 7.6 | 10.9 | – | – | – | – | 2,373.3 | 3,571.9 | 407.3 | 91.7 | 55.8 | 20.6 | 9.0 | 11.1 | 11.8 | 10.3 | 8.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 35.7 | 48.8 | 356.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 40.2 | 106.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -10.8% | -27.0% | -16.6% | -17.0% | -17.3% | -22.5% | -15.8% | -33.6% | -32.2% | -57.0% | -45.7% | -21.4% | -22.3% | -18.2% | -13.2% | -9.7% | -10.5% | -7.0% | -6.8% | -9.1% | -8.8% | 2.5% | 0.9% | -0.6% | -0.7% | -8.3% | -8.9% | -8.7% | -14.0% | -10.3% | -10.1% | -13.8% | -15.7% | -24.3% | -27.2% | -37.3% | -23.3% | -17.8% | -13.7% | -11.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.9% | 99.9% | 99.9% | 100.0% | 99.9% | 99.8% | 99.7% | 99.6% | – | – | – | – | 0.0% | 20.5% | 93.2% | 98.4% | 100.0% | 98.0% | 97.2% | 96.2% | 98.4% | 98.0% | 97.5% | |
| -3,057.7% | -3,587.4% | -3,950.0% | -4,376.9% | -4,393.9% | -2,939.0% | -3,140.6% | -3,264.1% | -3,263.2% | -5,001.7% | -4,676.1% | -4,440.3% | -4,131.0% | -3,792.9% | -3,812.0% | -3,893.5% | -4,335.4% | -4,708.2% | -5,503.4% | -5,880.7% | -661.5% | 18.8% | 11.9% | 0.8% | -11.0% | – | – | – | – | -42,901.7% | -49,151.5% | -7,135.5% | -1,942.5% | -1,434.4% | -786.6% | -433.7% | -275.1% | -158.4% | -102.9% | -77.1% | |
| -3,190.2% | -3,645.2% | -3,861.7% | -4,294.6% | -4,304.3% | -2,884.3% | -3,081.1% | -3,190.5% | -3,185.8% | -4,875.5% | -4,539.6% | -4,310.7% | -4,013.4% | -3,694.6% | -3,756.2% | -3,897.6% | -4,399.1% | -4,822.5% | -5,645.7% | -6,031.2% | -678.6% | 17.8% | 11.1% | 0.6% | -11.0% | – | – | – | – | -39,059.7% | -44,894.4% | -6,543.2% | -1,796.5% | -1,346.1% | -757.5% | -428.5% | -279.3% | -165.6% | -112.0% | -87.6% | |
| -2,403.9% | -2,903.1% | -3,405.7% | -3,802.2% | -3,697.3% | -2,251.2% | -2,512.8% | -2,578.9% | -2,850.9% | -4,529.9% | -4,318.1% | -4,145.2% | -3,489.9% | -3,336.3% | -3,276.6% | -3,862.1% | -4,506.0% | -4,697.4% | -5,136.7% | -5,310.6% | -645.4% | 20.8% | 6.9% | -4.8% | -8.1% | – | – | – | – | -29,962.9% | -38,231.5% | -5,976.1% | -1,565.5% | -1,160.9% | -655.3% | -387.1% | -278.8% | -187.5% | -128.2% | -87.6% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -41.5% | -52.9% | -64.9% | -47.9% | -54.3% | -58.3% | -77.3% | -102.3% | -115.5% | -139.4% | -100.3% | -118.3% | -138.2% | -177.4% | -106.5% | -40.0% | -50.6% | -29.0% | -37.5% | -42.6% | -46.1% | 6.1% | 4.1% | 0.2% | -4.1% | -31.9% | -35.2% | -40.1% | -49.0% | -37.8% | -48.9% | -60.8% | -81.1% | -110.6% | -154.0% | -212.8% | -269.9% | -441.6% | -584.4% | -1,462.1% | |
| -33.1% | -40.8% | -48.2% | -38.9% | -42.2% | -44.3% | -56.0% | -68.3% | -76.9% | -88.1% | -69.3% | -74.8% | -79.7% | -88.2% | -54.2% | -30.7% | -37.2% | -24.3% | -30.6% | -34.8% | -38.3% | 5.5% | 3.7% | 0.2% | -3.9% | -30.0% | -33.3% | -37.2% | -44.1% | -34.2% | -44.3% | -55.4% | -69.8% | -44.0% | -51.7% | -56.2% | -56.5% | -53.9% | -51.5% | -31.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -7.1 | -17 | – | – | -10 | -23 | -15 | -20 | -15 | -21 | -57 | -26 | -30 | -24 | -24 | -33 | -36 | -95 | -44 | -47 | -51 | -202 | -168 | -100 | -71 | -74 | -57 | -96 | -94 | -294 | -114 | -104 | -132 | 190 | -154 | -108 | -94 | 209 | 214 | 252 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.5 | -9.6 | -33.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 79.7% | 77.2% | 74.3% | 81.2% | 77.7% | 76.0% | 72.5% | 66.8% | 66.6% | 63.2% | 69.0% | 63.3% | 57.7% | 49.7% | 50.9% | 76.6% | 73.6% | 83.9% | 81.6% | 81.6% | 83.1% | 90.8% | 88.7% | 89.1% | 94.0% | 94.0% | 94.7% | 92.7% | 90.0% | 90.4% | 90.6% | 91.1% | 86.1% | 39.8% | 33.6% | 26.4% | 20.9% | 12.2% | 8.8% | 2.1% | |
| 0.1 | 0.1 | – | – | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 0.0 | 0.0 | 0.2 | 5.3 | 8.3 | 39.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2.17 | -2.44 | -2.58 | -2.69 | -2.36 | -2.54 | -2.75 | -2.91 | -2.91 | -2.76 | -2.55 | -2.07 | -1.92 | -1.77 | -1.66 | -1.46 | -1.51 | -1.59 | -1.66 | -1.77 | -1.76 | 0.47 | 0.26 | 0.01 | -0.23 | -2.36 | -2.21 | -2.30 | -2.52 | -2.89 | -2.82 | -3.10 | -3.48 | -3.72 | -3.87 | -3.88 | -3.60 | -3.30 | -2.81 | -2.48 | |
| 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.09 | 0.09 | 0.09 | 0.09 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.26 | 2.63 | 2.36 | 2.31 | 2.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.05 | 0.19 | 0.28 | 0.51 | 0.91 | 1.29 | 1.99 | 2.51 | 2.83 | |
| 5.24 | 4.62 | 3.98 | 5.61 | 4.35 | 4.36 | 3.55 | 2.85 | 2.52 | 1.98 | 2.54 | 1.75 | 1.39 | 1.00 | 1.56 | 3.64 | 2.99 | 5.48 | 4.43 | 4.16 | 3.83 | 7.68 | 6.35 | 6.02 | 5.57 | 7.40 | 6.27 | 5.74 | 5.14 | 7.64 | 5.77 | 5.09 | 4.29 | 3.36 | 2.51 | 1.82 | 1.33 | 0.75 | 0.48 | 0.17 | |
| -1.64 | -1.95 | -2.28 | -2.38 | -2.03 | -1.98 | -2.24 | -2.35 | -2.61 | -2.56 | -2.42 | -1.99 | -1.67 | -1.60 | -1.45 | -1.44 | -1.55 | -1.55 | -1.51 | -1.56 | -1.68 | 0.55 | 0.16 | -0.11 | -0.17 | -2.12 | -1.89 | -1.81 | -2.03 | -2.21 | -2.40 | -2.83 | -3.03 | -3.20 | -3.35 | -3.51 | -3.59 | -3.73 | -3.21 | -2.48 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.